Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators.

N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2.

2.

Apixaban for extended treatment of venous thromboembolism.

Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; PLIFY-EXT Investigators.

N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8.

3.

Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial.

Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators.

Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum in: Lancet Neurol. 2012 Dec;11(12):1021.

PMID:
22572202
4.

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.

Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW; TRACER Investigators.

N Engl J Med. 2012 Jan 5;366(1):20-33. doi: 10.1056/NEJMoa1109719. Epub 2011 Nov 13.

5.

Rivaroxaban in patients with a recent acute coronary syndrome.

Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM; ATLAS ACS 2–TIMI 51 Investigators.

N Engl J Med. 2012 Jan 5;366(1):9-19. doi: 10.1056/NEJMoa1112277. Epub 2011 Nov 13.

6.

Apixaban versus warfarin in patients with atrial fibrillation.

Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators.

N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.

7.

Apixaban with antiplatelet therapy after acute coronary syndrome.

Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L; APPRAISE-2 Investigators.

N Engl J Med. 2011 Aug 25;365(8):699-708. doi: 10.1056/NEJMoa1105819. Epub 2011 Jul 24.

8.

Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA; PLATO Investigators, Freij A, Thorsén M.

N Engl J Med. 2009 Sep 10;361(11):1045-57. doi: 10.1056/NEJMoa0904327. Epub 2009 Aug 30.

9.

Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

APPRAISE Steering Committee and Investigators, Alexander JH, Becker RC, Bhatt DL, Cools F, Crea F, Dellborg M, Fox KA, Goodman SG, Harrington RA, Huber K, Husted S, Lewis BS, Lopez-Sendon J, Mohan P, Montalescot G, Ruda M, Ruzyllo W, Verheugt F, Wallentin L.

Circulation. 2009 Jun 9;119(22):2877-85. doi: 10.1161/CIRCULATIONAHA.108.832139. Epub 2009 May 26.

10.
11.

Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.

Zeymer U, Tebbe U, Weber M, Vohringer HF, Jaksch R, Bischoff KO, Toepel W, Marsalek P, Horn S, Neuhaus KL; ALKK Study Group.

J Invasive Cardiol. 2003 Jul;15(7):385-9. Erratum in: J Invasive Cardiol. 2003 Sep;15(9):519.

PMID:
12840235
12.

Huge false aneurysm of left ventricular posterior wall following resection of an aneurysm of the left ventricular posterior wall.

Dubel HP, Rutsch W, Bohm J, Vohringer HF.

Catheter Cardiovasc Interv. 1999 Apr;46(4):509-10. No abstract available.

PMID:
10216027
13.

[Comparison of the clinical effect between digoxin and a diuretic in chronic left heart failure and sinus rhythm].

Vöhringer HF, Schüren KP.

Med Klin (Munich). 1993 Jul 15;88(7):410-6. German.

PMID:
8377718
14.

Pharmacokinetic optimisation in the treatment of Pneumocystis carinii pneumonia.

Vöhringer HF, Arastéh K.

Clin Pharmacokinet. 1993 May;24(5):388-412. Review.

PMID:
8504623
15.

Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT.

Link H, Vöhringer HF, Wingen F, Brägas B, Schwardt A, Ehninger G.

Bone Marrow Transplant. 1993 May;11(5):403-6.

PMID:
8504275
16.

[Risk factors and prevention of pneumocystis carinii pneumonia after bone marrow transplantation].

Link H, Vöhringer HF, Wingen F, Brägas B, Schwardt A, Ehninger G.

Med Klin (Munich). 1992 Oct;87 Suppl 1:39-42. German.

PMID:
1461227
17.

[Determinants of serum pentamidine concentration in the human].

Vöhringer HF, Arasteh K, Link H, Ehninger G, Hardtmann I.

Med Klin (Munich). 1992 Oct;87 Suppl 1:24-9. German.

PMID:
1461226
18.

[Initial experiences with pentamidine aerosol in prevention of Pneumocystis carinii pneumonia following bone marrow transplantation].

Link H, Schwardt A, Vöhringer HF, Wingen FJ, Haen M, Ehninger G.

Med Klin (Munich). 1990 Apr;85 Suppl 2:288-90. German.

PMID:
2374531
19.

[Pharmacologic studies with pentamidine aerosol in HIV patients].

Vöhringer HF, Arasteh K, Hardtmann E, Hornscheidt M.

Med Klin (Munich). 1990 Apr;85 Suppl 2:248-50, 291. German.

PMID:
2374528
20.

Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin.

Keller F, Kreutz G, Vöhringer HF, Offermann G, Distler A.

Clin Pharmacokinet. 1985 Nov-Dec;10(6):514-23.

PMID:
4064450
Items per page

Supplemental Content

Loading ...
Write to the Help Desk